The European Centre for Disease Prevention and Control (ECDC) and the European Food Safety Authority (EFSA) kindly invite you to join a webinar on West Nile virus and Usutu virus infections among humans and animals, with a focus on the situation in the European Union.
On 7 February 2021, an Ebola virus disease (EVD) outbreak was declared by the Ministry of Health of the Democratic Republic of the Congo (DRC), in the North Kivu province in the eastern part of the country.
This is the sixth update of a rapid risk assessment originally produced on 9 August 2018. The update addresses the impact of active chains of Ebola virus disease (EVD) transmission reported outside the outbreak’s epicentre, specifically in Goma, a provincial capital in the Democratic Republic of the Congo (DRC).
This is the fifth update of a rapid risk assessment originally produced on 9 August 2018. This rapid risk assessment addresses the potential public health impact of Ebola virus disease for EU/EEA countries and assesses the likelihood of international expansion.
This is the fourth update of a rapid risk assessment originally produced on 9 August 2018. This rapid risk assessment addresses the public health risk associated with the current Ebola virus outbreak in the DRC and its implications for EU/EEA citizens. It was triggered by an increase of EVD transmission in the affected areas over recent weeks, the persistent occurrence of new cases among contacts unknown at the time of EVD diagnosis, the occurrence of a substantial number of cases outside of the ring vaccination contacts and current challenges for the prevention and control of EVD.
This rapid risk assessment addresses the public health risk associated with the current Ebola virus outbreak in the Democratic Republic of the Congo (DRC) and its implications for EU/EEA citizens.
This is the second update of a rapid risk assessment originally produced on 9 August 2018. This rapid risk assessment addresses the public health risk associated with the current EVD outbreak in the DRC and its implications for EU/EEA citizens.